A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
Authors:
- Hidetaka UramotoHUHidetaka Uramoto
- Ryoichi NakanishiRNRyoichi Nakanishi
- Akira NagashimaANAkira Nagashima
- Akihiko UchiyamaAUAkihiko Uchiyama
- Masaaki InoueMIMasaaki Inoue
- Toshihiro OsakiTOToshihiro Osaki
- Takashi YoshimatsuTYTakashi Yoshimatsu
- Hisanobu SakataHSHisanobu Sakata
- Kozo NakanishiKNKozo Nakanishi
- Kosei YasumotoKYKosei Yasumoto
- 1 November 2010
- journal article
- research article
- Vol. 30 (11) , 4695-9